|
female |
37 |
|
humans |
35 |
|
male |
34 |
|
genetic predisposition to disease |
27 |
|
polymorphism, single nucleotide |
26 |
|
genotype |
24 |
|
polymorphism, single nucleotide - genetics |
24 |
|
adult |
22 |
|
middle aged |
22 |
|
single nucleotide polymorphism |
19 |
|
adolescent |
17 |
|
genetic susceptibility |
17 |
|
young adult |
16 |
|
case-control studies |
15 |
|
aged |
14 |
|
genetics |
14 |
|
antigens, cd - genetics |
13 |
|
bile duct atresia |
13 |
|
cell adhesion molecules - genetics |
13 |
|
chromosome 10q |
13 |
|
controlled study |
13 |
|
gene function |
13 |
|
gene identification |
13 |
|
gene locus |
13 |
|
genetic association |
13 |
|
human |
13 |
|
l-lactate dehydrogenase - blood |
13 |
|
major clinical study |
13 |
|
priority journal |
13 |
|
risk factor |
13 |
|
risk factors |
13 |
|
age factors |
12 |
|
china - epidemiology |
12 |
|
cohort studies |
12 |
|
gwa |
12 |
|
ret |
12 |
|
lumbar |
11 |
|
mutation |
11 |
|
animals |
10 |
|
asian continental ancestry group - genetics |
10 |
|
child |
10 |
|
chromosomes, human, pair 6 - genetics |
10 |
|
databases, genetic |
10 |
|
development |
10 |
|
gene expression regulation |
10 |
|
haplotypes |
10 |
|
lumbar disc degeneration |
10 |
|
mutations |
10 |
|
alleles |
9 |
|
asian continental ancestry group - ethnology |
9 |
|
association |
9 |
|
family health |
9 |
|
gene deletion |
9 |
|
gene frequency |
9 |
|
genome-wide association |
9 |
|
genome-wide association study |
9 |
|
haplotypes - genetics |
9 |
|
lumbar vertebrae |
9 |
|
pedigree |
9 |
|
aged, 80 and over |
8 |
|
allelic imbalance |
8 |
|
alzheimer's disease |
8 |
|
b-cell suppression |
8 |
|
cartilage |
8 |
|
china |
8 |
|
chinese |
8 |
|
copy number variation |
8 |
|
covid-19 |
8 |
|
cross-sectional studies |
8 |
|
degeneration |
8 |
|
degenerative disc disease |
8 |
|
disc |
8 |
|
dna mutational analysis |
8 |
|
gene duplication |
8 |
|
gene expression regulation, neoplastic |
8 |
|
genetic variation |
8 |
|
intervertebral |
8 |
|
intervertebral disc degeneration |
8 |
|
mitochondrial dysfunction |
8 |
|
mri |
8 |
|
nasopharyngeal neoplasms - genetics |
8 |
|
sars-cov-2 |
8 |
|
scoliosis |
8 |
|
superoxide dismutase - genetics |
8 |
|
5' untranslated regions - genetics |
7 |
|
a(h1n1)pdm09 influenza |
7 |
|
a(h7n9) influenza |
7 |
|
bmd |
7 |
|
bone density - genetics |
7 |
|
bone/joint abnormalities |
7 |
|
candidate gene |
7 |
|
cartilage diseases - genetics |
7 |
|
causality |
7 |
|
cer1 |
7 |
|
charcot-marie-tooth |
7 |
|
charcot-marie-tooth disease - genetics - pathology - physiopathology |
7 |
|
connexins - genetics |
7 |
|
disease progression |
7 |
|
electromyography |
7 |
|
extracellular matrix proteins - chemistry - genetics |
7 |
|
extracellular matrix proteins - genetics - physiology |
7 |
|
gene library |
7 |
|
genetic correlation |
7 |
|
genetic diseases, x-linked - genetics |
7 |
|
genetic variation - genetics |
7 |
|
genome scan |
7 |
|
genomics |
7 |
|
genotype-phenotype correlations |
7 |
|
gjb1 (connexin32) |
7 |
|
haplotype |
7 |
|
intervertebral disc - pathology |
7 |
|
intervertebral disk |
7 |
|
intervertebral disk displacement - complications - epidemiology - genetics |
7 |
|
linkage analysis |
7 |
|
linkage disequilibrium |
7 |
|
lung eqtl |
7 |
|
mapping complex traits |
7 |
|
matrix metalloproteinase 1 - genetics |
7 |
|
microscopy, electron, transmission |
7 |
|
neural conduction - genetics - physiology |
7 |
|
neuropathy |
7 |
|
non-coding region |
7 |
|
osteoarthritis |
7 |
|
peripheral nerves - pathology - physiopathology - ultrastructure |
7 |
|
phenotype |
7 |
|
pleiotropy |
7 |
|
point mutation - genetics |
7 |
|
polygenic score |
7 |
|
prevalence |
7 |
|
promoter regions, genetic |
7 |
|
pyrophosphatases - genetics - physiology |
7 |
|
sequence analysis |
7 |
|
severity of illness index |
7 |
|
spinal diseases - genetics |
7 |
|
tmprss2 |
7 |
|
vertebral disk displumbar vertebrae |
7 |
|
adolescent idiopathic scoliosis |
6 |
|
als |
6 |
|
amyotrophic lateral sclerosis - enzymology - genetics - pathology |
6 |
|
amyotrophic lateral sclerosis - genetics |
6 |
|
anisotropy |
6 |
|
asian continental ancestry group |
6 |
|
back pain - diagnosis - epidemiology |
6 |
|
ciliary neurotrophic factor - genetics |
6 |
|
clustering |
6 |
|
cntf |
6 |
|
col9a2 |
6 |
|
col9a3 |
6 |
|
collagen |
6 |
|
collagen type ix - genetics |
6 |
|
computational biology - methods |
6 |
|
cytokines - genetics |
6 |
|
diffusion magnetic resonance imaging - methods |
6 |
|
dna mutational analysis - methods |
6 |
|
dti |
6 |
|
exons - genetics |
6 |
|
familial |
6 |
|
familial amyotrophic lateral sclerosis |
6 |
|
fracture |
6 |
|
fractures, bone - genetics |
6 |
|
genetic disease |
6 |
|
genetic predisposition to disease - genetics |
6 |
|
genome-wide haplotype association mapping (ham) |
6 |
|
image processing, computer-assisted |
6 |
|
immunohistochemistry |
6 |
|
in situ hybridization |
6 |
|
incidence |
6 |
|
intervertebral disc displacement - diagnosis - epidemiology |
6 |
|
intervertebral disc displacement - epidemiology - genetics |
6 |
|
intervertebral disc herniation |
6 |
|
isoleucine - genetics |
6 |
|
loneliness |
6 |
|
low back pain |
6 |
|
lumbar vertebrae - pathology |
6 |
|
lumbar vertebrae - pathology - radiography |
6 |
|
magnetic resonance imaging |
6 |
|
magnetic resonance imaging - methods |
6 |
|
mice |
6 |
|
mice, inbred strains |
6 |
|
nonsymptomatic |
6 |
|
patterns of degeneration |
6 |
|
polymerase chain reaction |
6 |
|
polymorphism, restriction fragment length |
6 |
|
population based study |
6 |
|
predictive value of tests |
6 |
|
proteins - genetics |
6 |
|
receptors, calcitriol - genetics |
6 |
|
reverse transcriptase polymerase chain reaction |
6 |
|
reverse transcriptase polymerase chain reaction - methods |
6 |
|
sciatica - diagnosis - epidemiology |
6 |
|
sleep |
6 |
|
sod1 |
6 |
|
sod1 mutation |
6 |
|
southern chinese women |
6 |
|
spinal diseases - etiology - genetics - pathology |
6 |
|
statistics, nonparametric |
6 |
|
taq i |
6 |
|
taq polymerase - genetics |
6 |
|
threonine - genetics |
6 |
|
trp2 |
6 |
|
trp3 |
6 |
|
vascular endothelial growth factor a - genetics |
6 |
|
vegf |
6 |
|
vitamin d receptor |
6 |
|
alzheimer’s disease |
5 |
|
apolipoprotein e4 - genetics |
5 |
|
candidate gene approach |
5 |
|
carcinoma, non-small-cell lung - genetics |
5 |
|
child, preschool |
5 |
|
chromosomes, human, pair 3 - genetics |
5 |
|
cnv |
5 |
|
congenital scoliosis |
5 |
|
congenital vertebral malformation |
5 |
|
congenital vertebral malformation (cvm) |
5 |
|
copy number variant |
5 |
|
crispr/cas9 |
5 |
|
genes |
5 |
|
genes, tumor suppressor |
5 |
|
hemivertebrae |
5 |
|
hirschsprung disease - epidemiology - ethnology - genetics |
5 |
|
loss of heterozygosity |
5 |
|
lung neoplasms - genetics |
5 |
|
mapk7 |
5 |
|
mild cognitive impairment |
5 |
|
nucleic acid hybridization |
5 |
|
oncogene proteins - genetics |
5 |
|
polymorphism, genetic |
5 |
|
power |
5 |
|
receptor protein-tyrosine kinases - genetics |
5 |
|
reproducibility of results |
5 |
|
sex factors |
5 |
|
snp |
5 |
|
spectrometry, mass, matrix-assisted laser desorption-ionization |
5 |
|
tbx6 |
5 |
|
tbxt |
5 |
|
wga |
5 |
|
whole genome association |
5 |
|
whole-exome sequencing |
5 |
|
zebrafish |
5 |
|
abbreviated metal test |
4 |
|
algorithms |
4 |
|
alzheimer disease - genetics |
4 |
|
alzheimers disease assessment scale cognitive subscale |
4 |
|
amyloid beta protein |
4 |
|
antidepressive agents |
4 |
|
antigens, cd55 - genetics - immunology |
4 |
|
anxiety |
4 |
|
apoe ɛ4-negative |
4 |
|
apoe4 |
4 |
|
association study |
4 |
|
behavior, animal |
4 |
|
binding sites |
4 |
|
brain |
4 |
|
cardiovascular disease |
4 |
|
chromosomes, human, y - genetics |
4 |
|
civic engagement |
4 |
|
cobb angle |
4 |
|
cortisol |
4 |
|
cyclin-dependent kinase inhibitor p21 - biosynthesis - genetics |
4 |
|
cytokines |
4 |
|
depression |
4 |
|
dna, mitochondrial - genetics |
4 |
|
enzyme linked immunosorbent assay |
4 |
|
erbb4 |
4 |
|
europe |
4 |
|
extracellular matrix proteins - genetics |
4 |
|
familial aggregation |
4 |
|
functional magnetic resonance imaging |
4 |
|
gene expression profiling - instrumentation - methods |
4 |
|
gene mapping |
4 |
|
genetic linkage - genetics |
4 |
|
genetic polymorphism |
4 |
|
genetic predisposition to disease - epidemiology |
4 |
|
genetic testing |
4 |
|
genome, human |
4 |
|
glutamatergic system |
4 |
|
heart failure |
4 |
|
host susceptibilities |
4 |
|
ibd |
4 |
|
inbred mouse lines |
4 |
|
influenza (h7n9) virus |
4 |
|
influenza a virus, h1n1 subtype - immunology - pathogenicity |
4 |
|
influenza, human - genetics - immunology - pathology - virology |
4 |
|
information storage and retrieval - methods |
4 |
|
inherited escc |
4 |
|
intervention |
4 |
|
intervertebral disc degeneration - genetics - physiopathology |
4 |
|
intervertebral disk - metabolism - pathology - physiopathology |
4 |
|
intervertebral disk displacement - genetics - metabolism - physiopathology |
4 |
|
introns - genetics |
4 |
|
late-onset alzheimer's disease |
4 |
|
low back pain - genetics - physiopathology |
4 |
|
lumbar disk degeneration |
4 |
|
lupus erythematosus, systemic - blood - genetics |
4 |
|
magnetic resonance spectroscopy |
4 |
|
mirna-seq |
4 |
|
mlkl |
4 |
|
mouse |
4 |
|
mrna-seq |
4 |
|
neuritic elongation |
4 |
|
nrg3 |
4 |
|
older adults |
4 |
|
oligonucleotide array sequence analysis - instrumentation - methods |
4 |
|
organogenesis |
4 |
|
p21 |
4 |
|
perceived social support |
4 |
|
polymorphism |
4 |
|
positioning |
4 |
|
pro-neuronal survival |
4 |
|
prognosis |
4 |
|
protein blood level |
4 |
|
ptpn21 |
4 |
|
radiograph |
4 |
|
rct |
4 |
|
reference values |
4 |
|
regional index: eurasia |
4 |
|
sle |
4 |
|
snp array |
4 |
|
social network |
4 |
|
spinal cord |
4 |
|
spine |
4 |
|
stress |
4 |
|
susceptibility |
4 |
|
temporal dynamics |
4 |
|
twin studies |
4 |
|
volunteering |
4 |
|
whole exome sequencing |
4 |
|
abca1 |
3 |
|
age of onset |
3 |
|
aging |
3 |
|
alzheimer disease - blood |
3 |
|
alzheimer disease - blood - diagnosis - ethnology |
3 |
|
alzheimer disease - diagnosis - epidemiology - genetics |
3 |
|
alzheimer disease - ethnology - genetics |
3 |
|
alzheimer disease - genetics - physiopathology |
3 |
|
amyloid-β formation |
3 |
|
analysis of variance |
3 |
|
association studies |
3 |
|
atp-binding cassette transporters - genetics |
3 |
|
axonal transport |
3 |
|
beta-thalassemia - genetics |
3 |
|
bioinformatics |
3 |
|
biological availability |
3 |
|
biological markers - blood |
3 |
|
body mass index |
3 |
|
body weight - physiology |
3 |
|
bone mineral density |
3 |
|
case-control |
3 |
|
cell line, tumor |
3 |
|
cerebral amyloid angiopathy |
3 |
|
child development |
3 |
|
cholesterol metabolism |
3 |
|
chondrocytes |
3 |
|
chondrogenesis |
3 |
|
chromosomes, human, 16-18 |
3 |
|
chromosomes, human, x |
3 |
|
cognition - physiology |
3 |
|
cognition disorders - blood |
3 |
|
cognition disorders - genetics - physiopathology |
3 |
|
community health centers - trends |
3 |
|
complex disease |
3 |
|
computer simulation |
3 |
|
cyp46a 1 |
3 |
|
developmental spinal stenosis |
3 |
|
disease susceptibility loci |
3 |
|
dna primers |
3 |
|
dna, intergenic - genetics |
3 |
|
family |
3 |
|
fetal hemoglobin - genetics - metabolism |
3 |
|
follow-up studies |
3 |
|
genetic linkage |
3 |
|
genetic markers |
3 |
|
genetics, population |
3 |
|
genome - genetics |
3 |
|
genomics - methods |
3 |
|
geriatric assessment |
3 |
|
glucosephosphate dehydrogenase - blood - genetics |
3 |
|
glucosephosphate dehydrogenase deficiency - genetics |
3 |
|
hematopoietic stem cell transplantation - adverse effects |
3 |
|
heterozygote detection |
3 |
|
hypertension |
3 |
|
hypertension - blood - genetics |
3 |
|
hypertension - genetics |
3 |
|
immunoprecipitation |
3 |
|
infant |
3 |
|
insulin resistance |
3 |
|
interleukin-6 - genetics |
3 |
|
intervertebral disc degeneration - epidemiology - genetics - pathology |
3 |
|
linear models |
3 |
|
linkage |
3 |
|
men |
3 |
|
meta-analysis |
3 |
|
meta-analysis as topic |
3 |
|
metabolic syndrome |
3 |
|
microsatellite repeats |
3 |
|
microscopy, electron |
3 |
|
models, genetic |
3 |
|
neuropsychological tests |
3 |
|
osteoporosis |
3 |
|
osteoporosis - genetics |
3 |
|
polymorphism, genetic - genetics |
3 |
|
polymorphisms |
3 |
|
population |
3 |
|
population admixture |
3 |
|
prospective studies |
3 |
|
psychiatric status rating scales |
3 |
|
pyrophosphatases - genetics |
3 |
|
quantitative trait loci - genetics |
3 |
|
quantitative trait, heritable |
3 |
|
receptors, androgen - genetics |
3 |
|
restriction mapping |
3 |
|
set-based association test |
3 |
|
siblings |
3 |
|
simulation |
3 |
|
single nucleotide polymorphisms (snp) |
3 |
|
software |
3 |
|
steroid hydroxylases - genetics |
3 |
|
testosterone |
3 |
|
testosterone - blood |
3 |
|
tgcrnd8 mice |
3 |
|
tissue donors - statistics & numerical data |
3 |
|
transmission/disequilibrium test |
3 |
|
urotensin ii |
3 |
|
urotensins - genetics - metabolism |
3 |
|
waist circumference - physiology |
3 |
|
ad biomarkers |
2 |
|
adenine |
2 |
|
aggressive periodontitis - genetics - immunology |
2 |
|
aging - metabolism |
2 |
|
allelic expression |
2 |
|
alzheimer disease - diagnosis - enzymology - genetics |
2 |
|
alzheimer disease/*genetics |
2 |
|
alzheimer’s disease (ad) |
2 |
|
amyloid beta-peptides - antagonists & inhibitors - biosynthesis - toxicity |
2 |
|
amyloid plaques |
2 |
|
amyloid precursor protein |
2 |
|
analysis |
2 |
|
antioxidants - pharmacology |
2 |
|
apolipoproteins e/*genetics |
2 |
|
apolipoproteins e/genetics |
2 |
|
arterial spin labeling |
2 |
|
autophagy |
2 |
|
axonopathy |
2 |
|
aβ |
2 |
|
aβ aggregating elisa |
2 |
|
aβ plaque pathogenesis |
2 |
|
benzofurans - pharmacology |
2 |
|
blood–brain barrier (bbb) |
2 |
|
case-control study |
2 |
|
cell aggregation - drug effects |
2 |
|
cerebral blood flow |
2 |
|
cerebral perfusion |
2 |
|
cerebrospinal fluid |
2 |
|
chromosome mapping |
2 |
|
chronic periodontitis |
2 |
|
chronic periodontitis - genetics |
2 |
|
chronic periodontitis - genetics - immunology |
2 |
|
circadian rhythm |
2 |
|
circular dichroism |
2 |
|
circular dichroism spectroscopy |
2 |
|
clu polymorphisms |
2 |
|
cluster-randomized controlled trial |
2 |
|
cognitive decline |
2 |
|
complement c5 |
2 |
|
complement c5 - genetics |
2 |
|
crhr1 |
2 |
|
cyp46a1 |
2 |
|
cytosine |
2 |
|
cytotoxicity |
2 |
|
data interpretation, statistical |
2 |
|
dementia |
2 |
|
dentistry |
2 |
|
disordered proteins |
2 |
|
electron microscopy |
2 |
|
electronic microscope |
2 |
|
electrophoresis, polyacrylamide gel |
2 |
|
elsa |
2 |
|
enzyme-linked immunosorbent assay |
2 |
|
evolutionary rate |
2 |
|
fcγ receptor |
2 |
|
gene frequency - genetics |
2 |
|
gene regulation |
2 |
|
geneeenvironment interaction |
2 |
|
genome structure |
2 |
|
glucosephosphate dehydrogenase - genetics |
2 |
|
glucosephosphate dehydrogenase deficiency - epidemiology - genetics |
2 |
|
guanine |
2 |
|
hippocampal volumetry |
2 |
|
hla |
2 |
|
hong kong |
2 |
|
igg. |
2 |
|
immunologic factors - genetics |
2 |
|
kw048 - embryonic stem cell |
2 |
|
kw064 - functional motifs |
2 |
|
kw092 - inheritance patterns |
2 |
|
kw151 - regulation of transcription |
2 |
|
kw164 - systems biology |
2 |
|
leisure activities |
2 |
|
lineage specificity |
2 |
|
linkage disequilibrium - genetics |
2 |
|
medial temporal atrophy |
2 |
|
medical sciences |
2 |
|
melatonin |
2 |
|
memory performance |
2 |
|
meta& |
2 |
|
microfibrils - drug effects - ultrastructure |
2 |
|
microfluidic chips |
2 |
|
mild behavioural impairment |
2 |
|
next-generation sequencing |
2 |
|
paravascular space |
2 |
|
parenchymal plaques |
2 |
|
periodontitis |
2 |
|
periodontitis - genetics - immunology |
2 |
|
presenilin-1 |
2 |
|
presenilin-2 |
2 |
|
promoter regions, genetic - genetics |
2 |
|
receptor |
2 |
|
receptors |
2 |
|
receptors, igg - genetics |
2 |
|
salvianolic acid b |
2 |
|
serum lipids |
2 |
|
single-nucleotide |
2 |
|
smoking |
2 |
|
social environment |
2 |
|
tetrazolium salts |
2 |
|
thiazoles - pharmacology |
2 |
|
thioflavine t |
2 |
|
three-dimensional ad model |
2 |
|
tissue specificity |
2 |
|
trem2 |
2 |
|
variation and function |
2 |
|
x chromosome inactivation |
2 |
|
β amyloid |
2 |
|
β-amyloid fibrils |
2 |
|
*alleles |
1 |
|
*caenorhabditis elegans proteins |
1 |
|
*genetic linkage |
1 |
|
*genomic library |
1 |
|
*point mutation |
1 |
|
*polymorphism, genetic |
1 |
|
*signal transduction |
1 |
|
-491 a/t polymorphism |
1 |
|
9,10-dimethyl-1,2-benzanthracene - toxicity |
1 |
|
activity profiles of signalling pathways (apsp) |
1 |
|
adenocarcinoma |
1 |
|
adenocarcinoma - physiopathology |
1 |
|
african continental ancestry group/genetics |
1 |
|
age distribution |
1 |
|
alanine |
1 |
|
alpha-macroglobulins/*genetics/metabolism |
1 |
|
alternative splicing |
1 |
|
alzheimer disease |
1 |
|
alzheimer disease - complications - genetics - pathology |
1 |
|
alzheimer disease - epidemiology - genetics |
1 |
|
alzheimer disease/*enzymology/epidemiology/genetics |
1 |
|
alzheimer disease/*ethnology/*genetics |
1 |
|
alzheimer disease/*physiopathology |
1 |
|
alzheimer disease/blood/*genetics |
1 |
|
alzheimer disease/diagnosis/*genetics |
1 |
|
alzheimer disease/epidemiology/*genetics |
1 |
|
alzheimer disease/epidemiology/*genetics/metabolism |
1 |
|
alzheimer disease/metabolism |
1 |
|
amino acid sequence |
1 |
|
amyloid beta-peptides - metabolism |
1 |
|
amyloid beta-peptides/*genetics/metabolism |
1 |
|
amyloid beta-peptides/biosynthesis/genetics |
1 |
|
amyloid beta-peptides/metabolism |
1 |
|
amyloid beta-protein precursor - metabolism |
1 |
|
amyloid beta-protein precursor/*metabolism |
1 |
|
amyloid beta-protein precursor/genetics |
1 |
|
amyloid beta-protein precursor/genetics/*metabolism |
1 |
|
amyloid beta-protein precursor/metabolism |
1 |
|
amyloid precursor protein secretases |
1 |
|
amyloid β-peptide |
1 |
|
apoe ε2/ε3/ε4 polymorphism |
1 |
|
apolipoprotein e4 |
1 |
|
apolipoproteins e/genetics/metabolism |
1 |
|
apolipoproteins e/metabolism |
1 |
|
apoptosis |
1 |
|
apoptosis - drug effects |
1 |
|
app cleaving enzyme |
1 |
|
aspartic acid endopeptidases |
1 |
|
aspartic acid endopeptidases - genetics |
1 |
|
aspartic acid/*genetics |
1 |
|
aspartic acid/analogs & derivatives/genetics/*metabolism |
1 |
|
association analysis |
1 |
|
autosomal dominant |
1 |
|
aβ deposition |
1 |
|
base sequence |
1 |
|
binding sites/physiology |
1 |
|
biological markers |
1 |
|
body weight - drug effects |
1 |
|
boston |
1 |
|
brain - pathology |
1 |
|
brain/metabolism/ultrastructure |
1 |
|
breeding |
1 |
|
burrows-wheeler aligner |
1 |
|
caenorhabditis elegans |
1 |
|
caenorhabditis elegans/*genetics/metabolism |
1 |
|
carcinogens - toxicity |
1 |
|
caribbean region/ethnology |
1 |
|
cell compartmentation |
1 |
|
cell culture techniques |
1 |
|
cell division - drug effects |
1 |
|
cell line |
1 |
|
cell line, tumor - cytology - drug effects - physiology |
1 |
|
cell membrane |
1 |
|
cell membrane/*metabolism/ultrastructure |
1 |
|
cell proliferation |
1 |
|
cell proliferation - drug effects |
1 |
|
cells, cultured/cytology/metabolism |
1 |
|
chickens - genetics |
1 |
|
chromatin immunoprecipitation |
1 |
|
chromosome 12 |
1 |
|
chromosome aberrations/genetics |
1 |
|
chromosome disorders |
1 |
|
chromosome mapping/*veterinary |
1 |
|
chromosomes, human, pair 12 - genetics |
1 |
|
chromosomes, human, pair 12/*genetics |
1 |
|
chromosomes, human, pair 14/genetics |
1 |
|
cleidocranial dysostosis |
1 |
|
cleidocranial dysplasia |
1 |
|
clu and picalm |
1 |
|
clusterin - genetics |
1 |
|
coagulation factor viii |
1 |
|
codon/genetics |
1 |
|
cr1 |
1 |
|
cyclin d1 - metabolism |
1 |
|
cysteine endopeptidases/*genetics |
1 |
|
cysteine/*genetics |
1 |
|
damage assessment of genomic mutations (dagm) |
1 |
|
de novo assembly |
1 |
|
disease severity |
1 |
|
dna - isolation & purification |
1 |
|
dna binding |
1 |
|
dna binding motif |
1 |
|
dna probes |
1 |
|
dna synthesis |
1 |
|
dna, complementary |
1 |
|
dna, complementary/genetics |
1 |
|
dna/analysis |
1 |
|
dna/analysis/genetics |
1 |
|
dominican republic/ethnology |
1 |
|
endopeptidases |
1 |
|
endopeptidases/genetics/metabolism |
1 |
|
endopeptidases/metabolism |
1 |
|
endosomes - metabolism |
1 |
|
estrogen metabolic pathway |
1 |
|
ethnicity |
1 |
|
european continental ancestry group/*genetics |
1 |
|
european continental ancestry group/genetics |
1 |
|
exome sequencing |
1 |
|
exons |
1 |
|
f8 gene |
1 |
|
familial alzheimer's disease |
1 |
|
feasibility study |
1 |
|
foot |
1 |
|
freezing |
1 |
|
genes, dominant |
1 |
|
genetic association studies |
1 |
|
genetic testing/*methods |
1 |
|
germline rare coding mutations |
1 |
|
glycine |
1 |
|
gtp phosphohydrolases - genetics |
1 |
|
gtp-binding proteins |
1 |
|
gwas |
1 |
|
haemophilia |
1 |
|
helminth proteins/genetics/*metabolism |
1 |
|
her2 signalling pathway |
1 |
|
her2-negative breast cancer |
1 |
|
high-throughput nucleotide sequencing |
1 |
|
hispanic americans/*genetics |
1 |
|
hispanic americans/genetics |
1 |
|
immune suppression |
1 |
|
inflammation |
1 |
|
inhibitor |
1 |
|
interaction |
1 |
|
introns |
1 |
|
ldl-receptor related proteins - genetics |
1 |
|
lin-12 |
1 |
|
lod score |
1 |
|
mammary carcinogenesis |
1 |
|
mammary neoplasms, experimental - chemically induced - metabolism - pathology - prevention & control |
1 |
|
manhattan plot |
1 |
|
matrix metalloproteinase 1 - antagonists & inhibitors - metabolism |
1 |
|
matrix metalloproteinase 2 - antagonists & inhibitors - metabolism |
1 |
|
membrane glycoproteins/*genetics |
1 |
|
membrane glycoproteins/genetics/*metabolism |
1 |
|
membrane glycoproteins/genetics/*metabolism/*physiology |
1 |
|
membrane proteins - genetics |
1 |
|
membrane proteins/*genetics |
1 |
|
membrane proteins/*genetics/*metabolism |
1 |
|
membrane proteins/*genetics/metabolism |
1 |
|
membrane proteins/*metabolism |
1 |
|
membrane proteins/deficiency/*physiology |
1 |
|
membrane proteins/genetics/*metabolism |
1 |
|
membrane proteins/genetics/*physiology |
1 |
|
membrane transport proteins - genetics |
1 |
|
mice, inbred c57bl |
1 |
|
mice, knockout |
1 |
|
microglia activation |
1 |
|
models, statistical |
1 |
|
molecular sequence annotation |
1 |
|
molecular sequence data |
1 |
|
monomeric clathrin assembly proteins - genetics |
1 |
|
moscow/epidemiology |
1 |
|
multi-allelic |
1 |
|
multivariate analysis |
1 |
|
mutagenesis |
1 |
|
mutagenesis, insertional |
1 |
|
mutation, missense/physiology |
1 |
|
mutation/*genetics |
1 |
|
mutation/physiology |
1 |
|
neurofibrillary tangles/metabolism |
1 |
|
ngs platforms |
1 |
|
ngs tools |
1 |
|
norisoprenoids - pharmacology |
1 |
|
north carolina |
1 |
|
notch |
1 |
|
ontario/epidemiology |
1 |
|
open reading frames - genetics |
1 |
|
organ specificity |
1 |
|
paraplegia - complications - genetics - pathology |
1 |
|
peptide fragments/*genetics/metabolism |
1 |
|
peptide fragments/*metabolism |
1 |
|
peptide fragments/metabolism |
1 |
|
peptidyl-dipeptidase a/genetics/*metabolism |
1 |
|
plaque, amyloid - pathology |
1 |
|
point mutation/*genetics |
1 |
|
point mutation/genetics |
1 |
|
polymerase chain reaction/veterinary |
1 |
|
polymorphism, genetic/*genetics |
1 |
|
presenilin |
1 |
|
presenilin complexes |
1 |
|
proliferating cell nuclear antigen - metabolism |
1 |
|
protease nexins |
1 |
|
protein conformation |
1 |
|
protein processing, post-translational |
1 |
|
protein structure, tertiary/genetics |
1 |
|
protein structure, tertiary/physiology |
1 |
|
proto-oncogene proteins c-bcl-2 - metabolism |
1 |
|
puerto rico/ethnology |
1 |
|
qq plot |
1 |
|
quality control |
1 |
|
rats |
1 |
|
rats, sprague-dawley |
1 |
|
receptors, cell surface - metabolism |
1 |
|
receptors, complement 3b - genetics |
1 |
|
receptors, notch |
1 |
|
referral and consultation |
1 |
|
regulatory sequences, nucleic acid/*genetics |
1 |
|
retrospective studies |
1 |
|
risk assessment |
1 |
|
rna, messenger - analysis |
1 |
|
runx2 |
1 |
|
sel-12 |
1 |
|
sequence homology, amino acid |
1 |
|
short read mapping |
1 |
|
short reads mapping |
1 |
|
signal transduction/*physiology |
1 |
|
signal transduction/genetics |
1 |
|
software - standards |
1 |
|
spinal cord - pathology |
1 |
|
spine/*abnormalities |
1 |
|
stomach neoplasms |
1 |
|
stomach neoplasms - physiopathology |
1 |
|
supernumerary teeth |
1 |
|
survival analysis |
1 |
|
tissue inhibitor of metalloproteinase-1 - genetics |
1 |
|
tissue inhibitor of metalloproteinase-2 - genetics |
1 |
|
transfection |
1 |
|
turkeys/*genetics |
1 |
|
united states/epidemiology |
1 |
|
up-regulation - drug effects |
1 |
|
vesicular transport proteins - metabolism |
1 |
|
β-amyloid precursor protein |
1 |
|
β-ionone |
1 |
|
β-site |
1 |
|
γ-secretase |
1 |
